Waltham, MA, United States of America

Bioverativ USA Inc.


USPTO Granted Patents = 9



Forward Citations = 23

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Sandip Panicker (8 out of 24 patents)

silverMedal Graham Parry (8 out of 25 patents)

bronzeMedal Nancy E Stagliano (5 out of 41 patents)

4.  Peter Van Vlasselaer (4 out of 19 patents)

5.  Pavel A Nikitin (1 out of 1 patent)

6.  Tony Byun (1 out of 1 patent)

7.  Rene Belder (1 out of 3 patents)

8.  Stephen James Moore (1 out of 26 patents)

9.  Nazem Atassi (1 out of 1 patent)

10.  Pirouz Shamszad (1 out of 1 patent)

11.  Erik Holger Wallstroem (1 out of 1 patent)

12.  Miguel Alonso Alonso (1 out of 1 patent)

13.  Michael John Storek (1 out of 1 patent)

14.  Christopher Lawrence Vinnard (1 out of 1 patent)

15.  Yu Jyu Nancy Wong (1 out of 1 patent)


9 patents:

Company Overview
Bioverativ USA Inc. is a biopharmaceutical company focused on developing therapies for hemophilia and other rare blood disorders. With a commitment to innovation and patient care, Bioverativ is dedicated to improving the lives of those living with these conditions. Through research, development, and partnerships, Bioverativ strives to bring cutting-edge treatments to the market.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

9 Patents

#136 in Waltham, MA

#1,926 in Massachusetts

#32,588 in US

Waltham, MA (US)
Waltham, MA, United States of America
Forward Citations = 23

16 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bioverativ USA Inc.. Retrieved from https://idiyas.com/company/bioverativ-usa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…